Response of the hepatic and renal macrophage pool to novel spiro-linked heterocyclic compounds in rats
- Authors: Yukina G.Y.1, Sukhorukova E.G.1, Zhuravskii S.G.1, Polovnikov I.V.1, Kryzhanovskaia E.A.1, Boitsov V.M.2
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Petersburg National Research Academic University of the Russian Academy of Sciences
- Issue: Vol 23, No 3 (2025)
- Pages: 313-321
- Section: Original study articles
- URL: https://journals.rcsi.science/RCF/article/view/352624
- DOI: https://doi.org/10.17816/RCF680643
- EDN: https://elibrary.ru/PLLHRS
- ID: 352624
Cite item
Abstract
Background: The development of modern cancer therapies and new chemotherapeutic agents is ongoing. Heterocyclic compounds attract particular interest as promising therapeutic agents in the field of antitumor drug synthesis. A method for synthesizing spiro-linked pharmacophore fragments has recently been developed, resulting in spiro-linked barbiturates and oxindoles, a fundamentally new class of spirocyclic cycloadducts with expected antitumor activity. To assess the potential side effects of these novel compounds, it is crucial to evaluate their impact at the tissue and cellular levels, particularly on the liver and kidneys, as well as on macrophages, a critical component of the hepatic and renal mononuclear phagocyte system. Hepato- and nephrotoxicity are well-known adverse effects of many cytotoxic agents.
Aim: The work aimed to assess the response of the hepatic and renal macrophage pool to novel spiro-linked heterocyclic compounds in rats.
Methods: Male Wistar rats were divided into three groups. Animals in the control group received a single intraperitoneal injection of 1 mL of 0.9% sodium chloride solution. The other two groups received a single intraperitoneal injection of 1 mL of either a spiro-linked barbiturate (Compound 1; EG I) or a spiro-linked oxindole (Compound 2; EG II) at a dose of 12 mg/kg body weight. Animals were euthanized 2, 4, and 8 weeks after dosing. Tissue sections (5 µm thick) were prepared using standard histological techniques and stained with hematoxylin and eosin. Macrophages were detected immunocytochemically using anti-CD68 antibodies.
Results: Morphological analysis of the liver revealed endotheliitis in both experimental groups. Morphometric evaluation of the Kupffer cell pool demonstrated a significant increase in their number in EG I and EG II at all time points. Morphological analysis of the kidneys showed increased glomerular cellularity in both experimental groups, along with mild diffuse focal lymphomonocytic infiltration of the interstitium, which was more pronounced in EG II. The number of macrophages significantly increased in both experimental groups at 2 and 4 weeks, returning to control levels in EG I by week 8. In EG II, it remained significantly elevated compared with both the control and EG I groups.
Conclusion: Morphological examination indicated that the liver was the most sensitive to a single dose of the tested compounds. Reactive changes in the hepatic macrophage pool were observed in both experimental groups at all time points. The kidneys also responded to both compounds, with more pronounced changes in macrophage numbers in EG II. The macrophage pool response to the administered compounds in the examined organs was identical, with the spiro-linked oxindole showing a slightly greater toxic effect.
Full Text
##article.viewOnOriginalSite##About the authors
Galina Yu. Yukina
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: patlab1med@gmail.com
ORCID iD: 0000-0001-8888-4135
SPIN-code: 2533-2084
Cand. Sci. (Biology), Assistant Professor
Russian Federation, 6–8 L'va Tolstogo st, Saint Petersburg, 197022Elena G. Sukhorukova
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: patlab1med@gmail.com
ORCID iD: 0000-0001-5521-7248
SPIN-code: 2115-9041
MD, Cand. Sci. (Medicine)
Russian Federation, 6–8 L'va Tolstogo st, Saint Petersburg, 197022Sergei G. Zhuravskii
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: s.jour@mail.ru
ORCID iD: 0000-0002-5960-068X
SPIN-code: 5294-2096
MD, Dr. Sci. (Medicine)
Russian Federation, 6–8 L'va Tolstogo st, Saint Petersburg, 197022Ilia V. Polovnikov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: patlab1med@gmail.com
ORCID iD: 0000-0002-8633-8496
SPIN-code: 1509-7727
Russian Federation, 6–8 L'va Tolstogo st, Saint Petersburg, 197022
Elena A. Kryzhanovskaia
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: patlab1med@gmail.com
ORCID iD: 0000-0003-3791-8256
SPIN-code: 7261-0282
Russian Federation, 6–8 L'va Tolstogo st, Saint Petersburg, 197022
Vitali M. Boitsov
Petersburg National Research Academic University of the Russian Academy of Sciences
Email: bovitali@yandex.ru
ORCID iD: 0000-0002-4857-2046
SPIN-code: 3925-9999
MD, Cand. Sci. (Chemistry), Assistant Professor
Russian Federation, Saint PetersburgReferences
- Pronina YA, Viktorov NB, Selivanov SI, et al. Organocatalytic diastereoselective synthesis of spiro [3-azabicyclo [3.1.0]-hexanes] via 1,3-dipolar cycloaddition of azomethine ylides with cyclopropenes. Russ J Gen Chem. 2024;94(4):804–823. doi: 10.1134/S107036322404008X EDN: XEUTER
- Kornev AA, Shmakov SV, Gryschenko AM, et al. Study of cytotoxicity of 3-azabicyclo[3.1.0]hexanes and cyclopropa[a]pyrrolizidines spiro-fused to acenaphthylene-1(2H)-one and aceanthrylene-1(2H)-one fragments against tumor cell lines. Int J Mol Sci. 2025;26(8):3474. doi: 10.3390/ijms26083474
- Sukhorukova EG, Yukina GY, Polovnikov IV. Comparative pathomorphological analysis of the new spirofused heterocyclic compounds toxic effects on the rat hippocampus. Journal of Anatomy and Histopathology. 2025;14(1):74–82. doi: 10.18499/2225-7357-2025-14-1-74-82 EDN: KJHHMM
- Trukhan DI, Mazurov AL. Drug-induced liver disease: relevant issues of diagnosis and treatment. Medical Council. 2016;(5):70–73. (In Russ.) doi: 10.21518/2079-701X-2016-05-70-73 EDN: ZGSDLV
- Bell RMB, Conway BR. Macrophages in the kidney in health, injury and repair. Int Rev Cell Mol Biol. 2022;367:101–147. doi: 10.1016/bs.ircmb.2022.01.005 EDN: GOZOOB
- Kzhyshkovska JG, Stakheeva MN, Litvyakov NV, et al. Immune system and the efficacy of cancer treatment. Tomsk: Tomsk University Press; 2015. 164 p. (In Russ.) doi: 10.17223/978-5-7511-2391-8 EDN: VLHBBD
- Buscher K, Ehinger E, Gupta P, et al. Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival. Nat Commun. 2017;8:16041. doi: 10.1038/ncomms16041
- Amanzada A, Malik IA, Blaschke M, et al. Identification of CD68(+) neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease. Int J Clin Exp Pathol. 2013;6(4):561–570.
- Zigmond E, Samia-Grinberg S, Pasmanik-Chor M, et al. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol. 2014;193(1):344–353. doi: 10.4049/jimmunol.1400574
- Racanelli V. The liver as an immunological organ. Hepatology. 2006;43:S54–S62. doi: 10.1002/hep.21060
- Elbakidze GM. Mechanisms of protective influence of endotoxin-activated kupffer cells on hepatocytes. Annals of the Russian Academy of Medical Sciences. 2012;67(5):48–54. doi: 10.15690/vramn.v67i5.274 EDN: OYXWID
- Perepelyuk M. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol. 2013;304(6):G605–G614. doi: 10.1152/ajpgi.00222.2012
- Tang PMK, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–158. doi: 10.1038/s41581-019-0110-2 EDN: AXXTRX
- Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, et al. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192. doi: 10.3389/fphar.2019.01192
- Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10(9):493–503. doi: 10.1038/nrneph.2014.114
- Chen T, Cao Q, Wang Y, et al. M2 macrophages in kidney disease: biology, therapies, and perspectives. Kidney Int. 2019;95(4):760–773. doi: 10.1016/j.kint.2018.10.041 EDN: SORLOC
- Wen Y, Crowley SD. Renal effects of cytokines in hypertension. Adv Exp Med Biol. 2019;1165:443–454. doi: 10.1007/978-981-13-8871-2_21 EDN: SGRMNQ
- Bian Z, Gong Y, Huang T, et al. Deciphering human macrophage development at single-cell resolution. Nature. 2020;582(7813):571–576. doi: 10.1038/s41586-020-2316-7 EDN: YGPIBK
- Munro DAD, Hughes J. The origins and functions of tissue-resident macrophages in kidney development. Front Physiol. 2017;8:837. doi: 10.3389/fphys.2017.00837
- Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514. doi: 10.3389/fimmu.2014.00514

